IndraLab
Statements
reach
"Persistence of chemotherapy induced DNA damage has been observed in wild-type p53 glioblastoma cells [XREF_BIBR] as well as p53 deleted or mutant p53 ovarian cells [XREF_BIBR] treated with the first generation MDM2 antagonist Nutlin3a and this correlated with increases in MDM2 expression and cell death."
reach
"We show for the first time that in the presence of activated DNA damage checkpoint signaling, MDM2 acts to increase mutant p53 abundance, by facilitating monoubiquitination of mutant p53, and inactivation of checkpoint signaling serves as a switch that turns MDM2 from an activator of mutant p53 abundance to facilitating its degradation."
reach
"RNA interference showed that p53 knockdown increased the protein level of Gli1 but decreased the level of MDM2, and enhanced cell invasion and migration in wild-type p53 Capan-2 cells; whereas Gli1 or MDM2 knockdown did not change p53 expression, but decreased the protein level of MDM2 or Gli1, respectively, and inhibited cell invasion and migration in mutant p53 PANC-1 cells."